Study of Cabozantinib as Monotherapy or in Combination With Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Under Real-life Clinical Setting in 1st Line Treatment.
Clinical trial NCT03647878 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03647878
- Sponsor
- Ipsen
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2018-09-24
- Primary completion
- 2027-09-30
- Enrollment
- 224
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.